Evaluation of the Visby medical COVID-19 point of care nucleic acid amplification test

•Visby COVID-19 test correctly identified 96.7% positive and 98.6% negative samples.•Sensitivity of the method is as low as or lower than 500 copies/mL.•A result of invalid was observed with 2.0% of specimens.•Visby COVID-19 test is well-suited to address rapid SARS-CoV-2 testing needs. Rapid and wi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical biochemistry 2023-07, Vol.117, p.1-3
Hauptverfasser:	Katzman, Brooke M., Wockenfus, Amy M., Kelley, Brandon R., Karon, Brad S., Donato, Leslie J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronavirus disease 2019 (COVID-19) Nucleic acid amplification test (NAAT) Point of care (POC) Rapid test Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Short Communication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!